About Us
Products
Medical Information
Contact Us

About Us
Products
Medical Information
Contact Us

2020 – Cadila Healthcare Ltd. received USFDA approval to initiate clinical trials of desidustat in chemotherapy induced anemia (CIA).

Post navigation

Previous: 2020 – Zydus began supplying product in the US market from its Liva facility.

Next: 2020 – Zydus granted fast track designation by USFDA for Saroglitazar Mg in the treatment of patients with Primary Biliary Cholangitis (PBC).

© 2026 Zydus Canada Inc. All rights reserved.

About Us Products Contact Us Privacy Policy